Systems and methods for decrystallization of uric acid

Abstract

Systems and methods for treatment of hyperuricemia through the application of a base compound, such as, e.g., an antacid or alkali, are presented. Examples of an antacid or alkali includes, e.g., calcium carbonate, aluminum hydroxide, magnesium hydroxide, and sodium bicarbonate. The application uses a transdermal patch for preventing, minimizing or reversing hyperuricemia. The active ingredient or agent, e.g. antacid or alkali, may be distributed in the patch in any suitable manner. For example, a specified amount of the active ingredient or agent may be contained in a single drug-containing layer or multiple drug-containing layers. In addition to the active ingredient or agent, the drug-containing layer may comprise a carrier material for carrying the active ingredient or agent. The active ingredient or agent may be mixed with the carrier material, such as, e.g. homogenously blended, heterogeneously dispersed, encapsulated within, or any combination thereof.

Dependencies are inferred from the claim text.